CoJourney – A Reliable Partner For Your Product Process Development And Manufacturing
Expertise
- Extensive experience in process development and manufacturing, achieving a high success rate
- Industry-leading, unique Zero Chrom plasmid manufacturing platform offers low cost and minimal contamination risk.
- Industry-leading viral vector manufacturing platform delivers high yield, high purity products at lower cost per dose.
- Successfully served over 40 customers and completed more than 300 projects.
Quality
- State-of-the-art facilities and a robust quality system ensure compliance with FDA, EMA, and NMPA standards
- Proven track record of IND approvals with the FDA and CDE
- Comprehensive QC testing aligned with the latest regulatory standards
Cost
- Cojourney’s innovative manufacturing processes deliver both cost and environmental benefits.
- Unique process and facility design minimize facility footprint, resulting in lower CAPEX, OPEX, and FTE costs.
- Cojourney leverages a robust supply chain network and established vendor relationships to prioritize both quality and cost-efficiency.
CMC Expertise To Accelerate Your Drug Development Journey
Robust manufacturing solutions supported by regulatory and manufacturing expertise. Expediting the speed to market of your gene therapy product.
Plasmids
Viral Vectors
mRNA
Analytical Services
CoJourney: a reliable and innovation Partner of your Journey
CoJourney helps gene therapy companies around the world develop and manufacture their products:
- Developing the process and manufacturing your product in GMP
- Developing analytical methods and test your product
- Performing releasing of your product for use
CoJourney is revolutionizing plasmid production with their Zero Chrom Plasmid Platform. This innovative technology:
- Creates high-purity plasmids for gene therapy
- Reduces costs significantly
- Makes production faster and eliminating cross-contamination risks
Robust, scalable platform manufacturing technology for production of mRNA, Vectors, and plasmids at costs
60-70%lower than competitors
Leading Plasmids and AAV manufacturing platform with a proven track record of securing
FDA and CDE INDapprovals
Plasmid manufacturing can scale up to
30L
Viral vector manufacturing can scale up to
500L
mRNA can scale up to
>100g
Established partnerships with
40+clients
CoJourney: A Remarkable CDMO Experience
- Simple, stage-gated contracts to mitigate risks for clients.
- Expert Quality Control: Extensive expertise in Analytical and QA ensures product quality.
- Continuous Process Improvement: Continued improvements to manufacturing processes and technology for enhanced quality, yield and lower cost.
- Quality Materials and Supply Chain: We work with reputable suppliers, and source GMP-grade raw materials for quality, availability, and cost.
News & Events
CoJourney Funding Propels US Expansion
CoJourney secures $30 million financing and announces expansion of US production operations.
Upcoming Events
Advanced Therapies Week by Phacilitate, Maimi, FL – January 16-19
Cell & Gene Therapy at Pharma USA 2024, Philadelphia, PA – March 26-27
Cell & Gene Meeting on Med, Rome, Italy – April 9-11
ASGCT, Baltimore, MD – May 7-11
BIO 2024, San Diego, CA – June 3-6
ESGCT 2024, Rome, Italy – October 22-25
Contact Us
Connect with our experts to discuss how CoJourney can help you in the development of innovative cell and gene therapies.
Spring House Innovation Park
727 Norristown Road
Building 3, Suite 160
Lower Gwynedd, PA 19002
Let’s Chat!
+1 908 917 5558
BD@cojourney.comHangzhou CoJourney Bio Ltd. Bldg 15.
Hexiang Tech Center, Qiantang District,
Hangzhou City, Zhejiang Province